蓝帆医疗（002382）披露参与国家组织冠状动脉药物涂层球囊集中带量采购拟中选公告，1月14日股价上涨0.67%

Group 1 - The core point of the article is that Bluestar Medical (002382) has announced its participation in a national centralized procurement for coronary drug-coated balloons, with its product expected to be selected at a price of 2,524 yuan [1] - As of January 14, 2026, Bluestar Medical's stock closed at 5.99 yuan, reflecting a 0.67% increase from the previous trading day, with a total market capitalization of 6.033 billion yuan [1] - The procurement cycle for the selected products will last until December 31, 2028, and medical institutions are required to prioritize the purchase and use of the selected products [1] Group 2 - The stock opened at 5.95 yuan, reached a high of 6.07 yuan, and a low of 5.92 yuan on the same day, with a trading volume of 1.11 billion yuan and a turnover rate of 1.84% [1] - The announcement also indicates that the selection results are still in the public announcement phase, and there is uncertainty regarding the final results, contract signing, and execution [1]